一种涉及注射人体组织的新的抗衰老美容趋势，被称为“尸皮注射”，在香港女性中越来越受欢迎。该疗法使用了韩国L&C Bio公司开发、Humedix公司分销的Elravie Re2O，声称具有抗衰老功效。然而，香港卫生当局对其安全性和有效性表示质疑，因为该产品并未在香港注册使用。 AI
排序理由 该条目讨论的是一种美容产品及其市场反响，而非核心AI开发。
AI 生成摘要 · Google Gemini · 来自 1 个来源。 我们如何撰写摘要 →
香港女性拥抱“尸皮注射”美容趋势，但存在安全隐患
本文如何被排名
- Signal score
- 0 / 100
- Composite score across the factors below. Higher = stronger signal that this story matters right now.
- Newsworthiness bucket
- Tool
- 该条目讨论的是一种美容产品及其市场反响，而非核心AI开发。
- Source corroboration
- Single-source cluster
- Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
- Topics
- product, other
- Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
- AI-industry relevance
- Low
- Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
- Story freshness
- 1 days old
- Coverage has settled into its steady-state source set.
完整方法见我们的编辑标准。
报道来源 [1]
-
What is the ‘cadaver skin jab’ beauty trend and does it really work?
A growing interest among Hong Kong women in an anti-ageing injection containing human tissue has prompted a recent crackdown by health authorities, as the product, widely known in Chinese as the “cadaver skin jab”, has not been registered for use in the city. The South China Morn…